These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 17670845)
1. Elevated levels of TRAIL in systemic lupus erythematosus are associated to the presence of anti-SSA/SSB antibodies. Castellino G; Corallini F; Trotta F; Secchiero P Lupus; 2007; 16(7):479-82. PubMed ID: 17670845 [TBL] [Abstract][Full Text] [Related]
2. Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus. Lub-de Hooge MN; de Vries EG; de Jong S; Bijl M Ann Rheum Dis; 2005 Jun; 64(6):854-8. PubMed ID: 15564310 [TBL] [Abstract][Full Text] [Related]
3. Tumour necrosis factor-related apoptosis-inducing ligand and osteoprotegerin serum levels in psoriatic arthritis. Hofbauer LC; Schoppet M; Christ M; Teichmann J; Lange U Rheumatology (Oxford); 2006 Oct; 45(10):1218-22. PubMed ID: 16574701 [TBL] [Abstract][Full Text] [Related]
4. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis. Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137 [TBL] [Abstract][Full Text] [Related]
5. Up regulation of serum tumor necrosis factor-related apoptosis inducing ligand in juvenile-onset systemic lupus erythematosus: relations with disease activity, antibodies to double -stranded DNA, nephritis and neutropenia. Ezzat MH; El-Gammasy TM; Shaheen KY; El-Mezdawi RA; Youssef MS Int J Rheum Dis; 2013 Jun; 16(3):310-8. PubMed ID: 23981753 [TBL] [Abstract][Full Text] [Related]
6. Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with active systemic lupus erythematosus. Komatsuda A; Wakui H; Iwamoto K; Togashi M; Maki N; Masai R; Hatakeyama T; Sawada K Clin Immunol; 2007 Oct; 125(1):26-9. PubMed ID: 17683987 [TBL] [Abstract][Full Text] [Related]
7. [Anti-SSA/Ro and anti-SSB/La antibodies. What's new?]. Meyer O Ann Med Interne (Paris); 2002 Dec; 153(8):520-9. PubMed ID: 12610426 [TBL] [Abstract][Full Text] [Related]
8. Increased expression and release of functional tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by T cells from lupus patients with active disease. Rus V; Zernetkina V; Puliaev R; Cudrici C; Mathai S; Via CS Clin Immunol; 2005 Oct; 117(1):48-56. PubMed ID: 15961346 [TBL] [Abstract][Full Text] [Related]
9. Serum osteoprotegerin and tumor necrosis factor related apoptosis inducing-ligand (TRAIL) are elevated in type 2 diabetic patients with albuminuria and serum osteoprotegerin is independently associated with the severity of diabetic nephropathy. Chang YH; Lin KD; He SR; Hsieh MC; Hsiao JY; Shin SJ Metabolism; 2011 Aug; 60(8):1064-9. PubMed ID: 21251686 [TBL] [Abstract][Full Text] [Related]
10. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome. Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014 [TBL] [Abstract][Full Text] [Related]
11. Autoimmune response in mothers of children with congenital and postnatally diagnosed isolated heart block: a population based study. Julkunen H; Miettinen A; Walle TK; Chan EK; Eronen M J Rheumatol; 2004 Jan; 31(1):183-9. PubMed ID: 14705240 [TBL] [Abstract][Full Text] [Related]
12. Circulating osteoprotegerin levels are elevated and correlated with antiphospholipid antibodies in patients with systemic lupus erythematosus. Kwok SK; Shin YJ; Kim HJ; Kim HS; Kim JY; Yoo SA; Choi JJ; Kim WU; Cho CS Lupus; 2009 Feb; 18(2):133-8. PubMed ID: 19151114 [TBL] [Abstract][Full Text] [Related]
13. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations. Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265 [TBL] [Abstract][Full Text] [Related]
14. Autoantibodies against alpha-fodrin in Sjögren's syndrome with neurological manifestations. de Seze J; Dubucquoi S; Fauchais AL; Hachulla E; Matthias T; Lefranc D; Hatron PY; Vermersch P; Witte T J Rheumatol; 2004 Mar; 31(3):500-3. PubMed ID: 14994394 [TBL] [Abstract][Full Text] [Related]
15. Detection by ELISA of antibodies to small RNA protein particles in systemic lupus erythematosus patients whose sera lack precipitins. Reichlin M; Harley JB Trans Assoc Am Physicians; 1986; 99():161-71. PubMed ID: 3496697 [TBL] [Abstract][Full Text] [Related]
16. [Correlation of anti-60000 SSA antibody and anti-52000 SSA antibody with systemic lupus erythematosus and Sjögren's syndrome]. Zhang FC; Liu L; Xu D Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(1):7-10. PubMed ID: 17403303 [TBL] [Abstract][Full Text] [Related]
17. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome. Manoussakis MN; Georgopoulou C; Zintzaras E; Spyropoulou M; Stavropoulou A; Skopouli FN; Moutsopoulos HM Arthritis Rheum; 2004 Mar; 50(3):882-91. PubMed ID: 15022331 [TBL] [Abstract][Full Text] [Related]
18. Serum IgA against type 3 muscarinic acetylcholine receptor is a novel marker in diagnosis of Sjögren's syndrome. Li YN; Guo JP; He J; Liu X; Yin FR; Ding Y; Yao HH; Kang AJ; Li ZG Chin Med J (Engl); 2011 Aug; 124(16):2490-5. PubMed ID: 21933593 [TBL] [Abstract][Full Text] [Related]
19. Anti-CD43 and anti-galectin-1 autoantibodies in patients with systemic lupus erythematosus. Montiel JL; Monsiváis-Urenda A; Figueroa-Vega N; Moctezuma JF; Burgos-Vargas R; González-Amaro R; Rosenstein Y Scand J Rheumatol; 2010; 39(1):50-7. PubMed ID: 20132071 [TBL] [Abstract][Full Text] [Related]
20. Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity. Kuryliszyn-Moskal A; Ciolkiewicz M; Klimiuk PA; Sierakowski S Scand J Rheumatol; 2009; 38(1):38-45. PubMed ID: 18991188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]